NUVA Nuvasive Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUVA

Price (delayed)

$64.61

Market cap

$3.34B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.98

Enterprise value

$4.1B

Highlights
NUVA's quick ratio has surged by 118% year-on-year and by 32% since the previous quarter
The debt has contracted by 35% from the previous quarter and by 10% YoY
NUVA's EPS has shrunk by 183% YoY and by 36% QoQ
Nuvasive's net income has plunged by 182% YoY and by 34% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.nuvasive.com/
Peers: OFIX ATEC SYK GMED

Key stats

What are the main financial stats of NUVA
Market
Shares outstanding
51.65M
Market cap
$3.34B
Enterprise value
$4.1B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.97
Price to sales (P/S)
3.13
EV/EBIT
3,478.07
EV/EBITDA
28.56
EV/Sales
3.86
Earnings
Revenue
$1.06B
EBIT
$1.18M
EBITDA
$143.58M
Free cash flow
$109.64M
Per share
EPS
-$0.98
Free cash flow per share
$2.13
Book value per share
$16.26
Revenue per share
$20.67
TBVPS
$23.98
Balance sheet
Total assets
$2.16B
Total liabilities
$1.33B
Debt
$998.96M
Equity
$835.39M
Working capital
$556.68M
Liquidity
Debt to equity
1.2
Current ratio
3.48
Quick ratio
1.96
Net debt/EBITDA
5.32
Margins
EBITDA margin
13.5%
Gross margin
69.7%
Net margin
-4.7%
Operating margin
2.1%
Efficiency
Return on assets
-2%
Return on equity
-5.6%
Return on invested capital
0.1%
Return on capital employed
0.1%
Return on sales
0.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVA stock price

How has the Nuvasive stock price performed over time
Intraday
1%
1 week
1.02%
1 month
-5.21%
1 year
11.55%
YTD
14.7%
QTD
-4.68%

Financial performance

How have Nuvasive's revenue and profit performed over time
Revenue
$1.06B
Gross profit
$740.37M
Operating income
$22.32M
Net income
-$49.96M
Gross margin
69.7%
Net margin
-4.7%
The net margin has plunged by 189% YoY and by 34% from the previous quarter
Nuvasive's net income has plunged by 182% YoY and by 34% from the previous quarter
The company's operating income has shrunk by 83% YoY and by 42% QoQ
NUVA's operating margin has dropped by 82% year-on-year and by 42% since the previous quarter

Growth

What is Nuvasive's growth rate over time

Valuation

What is Nuvasive stock price valuation
P/E
N/A
P/B
3.97
P/S
3.13
EV/EBIT
3,478.07
EV/EBITDA
28.56
EV/Sales
3.86
NUVA's EPS has shrunk by 183% YoY and by 36% QoQ
NUVA's price to book (P/B) is 20% more than its last 4 quarters average of 3.3
The equity has contracted by 9% from the previous quarter and by 6% YoY
The price to sales (P/S) is 16% higher than the last 4 quarters average of 2.7 and 4.3% higher than the 5-year quarterly average of 3.0
Nuvasive's revenue has decreased by 8% YoY

Efficiency

How efficient is Nuvasive business performance
The company's return on equity has shrunk by 181% YoY and by 37% QoQ
The return on assets has dropped by 163% year-on-year and by 33% since the previous quarter
NUVA's ROS has shrunk by 99% YoY and by 95% QoQ
The company's return on invested capital has shrunk by 99% YoY and by 93% QoQ

Dividends

What is NUVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVA.

Financial health

How did Nuvasive financials performed over time
The total assets is 63% greater than the total liabilities
NUVA's current ratio has surged by 158% year-on-year and by 86% since the previous quarter
NUVA's quick ratio has surged by 118% year-on-year and by 32% since the previous quarter
The debt is 20% more than the equity
The debt has contracted by 35% from the previous quarter and by 10% YoY
NUVA's debt to equity is down by 28% since the previous quarter and by 4.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.